Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Amortization of Goodwill: 2024

Historic Amortization of Goodwill for Maravai Lifesciences Holdings (MRVI) over the last 1 years, with Dec 2024 value amounting to $166.2 million.

  • Maravai Lifesciences Holdings' Amortization of Goodwill was N/A to $30.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $363.3 million, marking a year-over-year change of. This contributed to the annual value of $166.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Amortization of Goodwill of $166.2 million as of FY2024.
  • Maravai Lifesciences Holdings' Amortization of Goodwill's 5-year high stood at $166.2 million during FY2024, with a 5-year trough of $166.2 million in FY2024.
  • In the last 1 years, Maravai Lifesciences Holdings' Amortization of Goodwill had a median value of $166.2 million in 2024 and averaged $166.2 million.